Maze Therapeutics Stock Still Climbing After March Tumble
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
A major fund just raised its stake in a leading data-center company. This article breaks down what that move could me...
When a top investor steps up after a steep drop, it signals conviction. This deep dive looks at why First Beijing bou...
A china tech fund opens a biotech position, signaling a broader shift toward life sciences within tech-driven portfol...
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
A big hedge fund dumped its entire ServisFirst stake, triggering questions about risk and valuation in regional banks...
KBR has endured a tough year, with the stock fallen this past year by about 45%. A fresh stake worth $24 million from...
A middle-aged couple with a sizable traditional retirement balance confronts a looming tax spike as required withdraw...
Two Navy jets collided during an Idaho air show, and four crew members ejected safely. The incident triggered a base ...
Dow futures slid while oil prices rose as Iran’s stalemate keeps a risk premium in play. Markets brace for inflation ...
A Colorado resident was drawn into a high-pressure sales pitch for a $1 million fixed indexed annuity, featuring a ph...